Gene expression profiling of transporters in the solute carrier and ATP-binding cassette superfamilies in human eye substructures.
暂无分享,去创建一个
K. Giacomini | A. Dahlin | J. Siegenthaler | A. Basile | D. Tang-Liu | C. Cropp | Ethan G. Geier | E. Grigorenko | S. Stocker | M. Bloomer | Lu Xu
[1] Asim V. Farooq,et al. Herpes simplex epithelial and stromal keratitis: an epidemiologic update. , 2012, Survey of ophthalmology.
[2] C. Keilhauer,et al. A subgroup of age-related macular degeneration is associated with mono-allelic sequence variants in the ABCA4 gene. , 2012, Investigative ophthalmology & visual science.
[3] L. Aleksunes,et al. Expression of Organic Anion Transporter 2 in the Human Kidney and Its Potential Role in the Tubular Secretion of Guanine-Containing Antiviral Drugs , 2012, Drug Metabolism and Disposition.
[4] K. Kaarniranta,et al. Efflux Protein Expression in Human Stem Cell-Derived Retinal Pigment Epithelial Cells , 2012, PloS one.
[5] J. I. Korenbrot,et al. Speed, adaptation, and stability of the response to light in cone photoreceptors: The functional role of Ca-dependent modulation of ligand sensitivity in cGMP-gated ion channels , 2012, The Journal of general physiology.
[6] R. Bendayan,et al. Expression of ATP-Binding Cassette Membrane Transporters in Rodent and Human Sertoli Cells: Relevance to the Permeability of Antiretroviral Therapy at the Blood-Testis Barrier , 2012, Journal of Pharmacology and Experimental Therapeutics.
[7] I. Holland,et al. ABC transporters, mechanisms and biology: an overview. , 2011, Essays in biochemistry.
[8] M. Ott,et al. The ABC of the blood-brain barrier - regulation of drug efflux pumps. , 2011, Current pharmaceutical design.
[9] Gideon Koren,et al. Acyclovir is a substrate for the human breast cancer resistance protein (BCRP/ABCG2): implications for renal tubular transport and acyclovir-induced nephrotoxicity. , 2011, Canadian journal of physiology and pharmacology.
[10] R. Pelletier. The blood-testis barrier: the junctional permeability, the proteins and the lipids. , 2011, Progress in histochemistry and cytochemistry.
[11] J. Handa,et al. Lipids, Lipoproteins, and Age-Related Macular Degeneration , 2011, Journal of lipids.
[12] M. Daly,et al. Association of variants in the LIPC and ABCA1 genes with intermediate and large drusen and advanced age-related macular degeneration. , 2011, Investigative ophthalmology & visual science.
[13] V. Sheffield,et al. Genomics and the eye. , 2011, The New England journal of medicine.
[14] G. Quellec,et al. Computational quantification of complex fundus phenotypes in age-related macular degeneration and Stargardt disease. , 2011, Investigative ophthalmology & visual science.
[15] P. Elliott,et al. Meta-Analysis of Genome-Wide Association Studies in >80 000 Subjects Identifies Multiple Loci for C-Reactive Protein Levels , 2011, Circulation.
[16] C. Ramirez,et al. Molecular genetic basis for fluoroquinolone-induced retinal degeneration in cats , 2011, Pharmacogenetics and genomics.
[17] David J. Calkins,et al. Brimonidine prevents axonal and somatic degeneration of retinal ganglion cell neurons , 2011, Molecular Neurodegeneration.
[18] C. Dinarello,et al. Blocking interleukin‐1β in acute and chronic autoinflammatory diseases , 2011, Journal of internal medicine.
[19] A. Subrizi,et al. Barrier analysis of periocular drug delivery to the posterior segment. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[20] Akiyoshi Uemura,et al. MRP4 knockdown enhances migration, suppresses apoptosis, and produces aggregated morphology in human retinal vascular endothelial cells. , 2010, Biochemical and biophysical research communications.
[21] Ken-ichi Hosoya,et al. The role of blood–ocular barrier transporters in retinal drug disposition: an overview , 2010, Expert opinion on drug metabolism & toxicology.
[22] H. Glaeser,et al. The prostaglandin transporter OATP2A1 is expressed in human ocular tissues and transports the antiglaucoma prostanoid latanoprost. , 2010, Investigative ophthalmology & visual science.
[23] Margaret A. Pericak-Vance,et al. Genetic variants near TIMP3 and high-density lipoprotein–associated loci influence susceptibility to age-related macular degeneration , 2010, Proceedings of the National Academy of Sciences.
[24] M. Niemi,et al. Membrane transporters in drug development , 2010, Nature Reviews Drug Discovery.
[25] B. Ambati,et al. Corneal transparency: Genesis, maintenance and dysfunction , 2010, Brain Research Bulletin.
[26] M. Häkli,et al. Effluxing ABC transporters in human corneal epithelium. , 2010, Journal of pharmaceutical sciences.
[27] B. Hagenbuch. Drug Uptake Systems in Liver and Kidney: A Historic Perspective , 2010, Clinical pharmacology and therapeutics.
[28] P. Donnelly,et al. Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region , 2010 .
[29] A. Negi,et al. Expression of ATP-binding cassette transporters at the inner blood–retinal barrier in a neonatal mouse model of oxygen-induced retinopathy , 2009, Brain Research.
[30] J. Hohmann,et al. Expression Profiling of the Solute Carrier Gene Family in the Mouse Brain , 2009, Journal of Pharmacology and Experimental Therapeutics.
[31] G. Mishra,et al. Enhanced Corneal Absorption of Erythromycin by Modulating P-Glycoprotein and MRP Mediated Efflux with Corticosteroids , 2009, Pharmaceutical Research.
[32] K. Kaarniranta,et al. Efflux Protein Expression in Human Retinal Pigment Epithelium Cell Lines , 2009, Pharmaceutical Research.
[33] T. Terasaki,et al. Roles of Inner Blood-Retinal Barrier Organic Anion Transporter 3 in the Vitreous/Retina-to-Blood Efflux Transport of p-Aminohippuric Acid, Benzylpenicillin, and 6-Mercaptopurine , 2009, Journal of Pharmacology and Experimental Therapeutics.
[34] A. Mitra,et al. Expression of multidrug resistance associated protein 5 (MRP5) on cornea and its role in drug efflux. , 2009, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
[35] M. Lavail,et al. Expression of Reverse Cholesterol Transport Proteins Atp- Binding Cassette A1 (abca1) and Scavenger Receptor Bi (sr-bi) in the Retina and Retinal Pigment Epithelium Nih Public Access Author Manuscript $watermark-text , 2022 .
[36] F. Russel,et al. The Role of ATP Binding Cassette Transporters in Tissue Defense and Organ Regeneration , 2009, Journal of Pharmacology and Experimental Therapeutics.
[37] A. Mitra,et al. Molecular Expression and Functional Evidence of a Drug Efflux Pump (BCRP) in Human Corneal Epithelial Cells , 2009, Current eye research.
[38] J. Weinstein,et al. Profiling SLCO and SLC22 genes in the NCI-60 cancer cell lines to identify drug uptake transporters , 2008, Molecular Cancer Therapeutics.
[39] M. Hauser,et al. NEIBank: Genomics and bioinformatics resources for vision research , 2008, Molecular vision.
[40] Tao Zhang,et al. Drug Transporter and Cytochrome P450 mRNA Expression in Human Ocular Barriers: Implications for Ocular Drug Disposition , 2008, Drug Metabolism and Disposition.
[41] Swati S. More,et al. Organic Anion Transporter 2 (SLC22A7) Is a Facilitative Transporter of cGMP , 2008, Molecular Pharmacology.
[42] E. Petzinger,et al. Molecular and phylogenetic characterization of a novel putative membrane transporter (SLC10A7), conserved in vertebrates and bacteria. , 2007, European journal of cell biology.
[43] S. Nigam,et al. Drug and toxicant handling by the OAT organic anion transporters in the kidney and other tissues , 2007, Nature Clinical Practice Nephrology.
[44] Osamu Ogawa,et al. Substrate specificity of MATE1 and MATE2-K, human multidrug and toxin extrusions/H(+)-organic cation antiporters. , 2007, Biochemical pharmacology.
[45] R. Hevner,et al. Expression and immunolocalization of the plasma membrane monoamine transporter in the brain , 2007, Neuroscience.
[46] H. Stöhr,et al. Bmc Molecular Biology Three Novel Abcc5 Splice Variants in Human Retina and Their Role as Regulators of Abcc5 Gene Expression , 2022 .
[47] A. Mitra,et al. Molecular evidence and functional expression of a novel drug efflux pump (ABCC2) in human corneal epithelium and rabbit cornea and its role in ocular drug efflux. , 2007, International journal of pharmaceutics.
[48] Shiyao Xu,et al. Transport of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin by Human Organic Anion Transporter 3, Organic Anion Transporting Polypeptide 4C1, and Multidrug Resistance P-glycoprotein , 2007, Journal of Pharmacology and Experimental Therapeutics.
[49] H. Kato,et al. Modulation of drug-stimulated ATPase activity of human MDR1/P-glycoprotein by cholesterol. , 2007, The Biochemical journal.
[50] Kati-Sisko Vellonen,et al. Drug transport in corneal epithelium and blood-retina barrier: emerging role of transporters in ocular pharmacokinetics. , 2006, Advanced drug delivery reviews.
[51] V. Douet,et al. HNF4alpha and NF-E2 are key transcriptional regulators of the murine Abcc6 gene expression. , 2006, Biochimica et biophysica acta.
[52] B. Giros,et al. Differential pharmacological in vitro properties of organic cation transporters and regional distribution in rat brain , 2006, Neuropharmacology.
[53] Masahiko Watanabe,et al. ATP-Binding Cassette Transporter G2 Mediates the Efflux of Phototoxins on the Luminal Membrane of Retinal Capillary Endothelial Cells , 2006, Pharmaceutical Research.
[54] J. Wenzel,et al. ABC A-subfamily transporters: structure, function and disease. , 2006, Biochimica et biophysica acta.
[55] H. Sasaki,et al. Transport of acebutolol through rabbit corneal epithelium. , 2006, Biological & pharmaceutical bulletin.
[56] Brian R. Phillips,et al. INTERACTIONS OF AMOXICILLIN AND CEFACLOR WITH HUMAN RENAL ORGANIC ANION AND PEPTIDE TRANSPORTERS , 2006, Drug Metabolism and Disposition.
[57] Matthew W. Wilson,et al. Immunohistochemical detection of multidrug-resistant protein expression in retinoblastoma treated by primary enucleation. , 2006, Investigative ophthalmology & visual science.
[58] R. Neubert,et al. Drug specificity and intestinal membrane localization of human organic cation transporters (OCT). , 2005, Biochemical pharmacology.
[59] G. Abecasis,et al. Toll-like receptor 4 variant D299G is associated with susceptibility to age-related macular degeneration. , 2005, Human molecular genetics.
[60] Guy Perrière,et al. MADE4: an R package for multivariate analysis of gene expression data , 2005, Bioinform..
[61] Toshinori Yamamoto,et al. Transport mechanism and substrate specificity of human organic anion transporter 2 (hOat2 [SLC22A7]) , 2005, The Journal of pharmacy and pharmacology.
[62] Toshinori Yamamoto,et al. POSSIBLE INVOLVEMENT OF ORGANIC ANION TRANSPORTER 2 ON THE INTERACTION OF THEOPHYLLINE WITH ERYTHROMYCIN IN THE HUMAN LIVER , 2005, Drug Metabolism and Disposition.
[63] P. Meier,et al. The Human Organic Anion Transporter 2 Gene Is Transactivated by Hepatocyte Nuclear Factor-4α and Suppressed by Bile Acids , 2005, Molecular Pharmacology.
[64] E. Miserocchi,et al. Comparison of the Efficacy of Valacyclovir vs Acyclovir for the Prevention of Recurrent Herpes Simplex Virus Eye Disease , 2005 .
[65] A. Urtti,et al. Permeability of retinal pigment epithelium: effects of permeant molecular weight and lipophilicity. , 2005, Investigative ophthalmology & visual science.
[66] G. You. The role of organic ion transporters in drug disposition: an update. , 2004, Current drug metabolism.
[67] Andreas Rolfs,et al. The ABCs of solute carriers: physiological, pathological and therapeutic implications of human membrane transport proteins , 2004, Pflügers Archiv.
[68] Maristela L Onozato,et al. Interaction of human and rat organic anion transporter 2 with various cephalosporin antibiotics. , 2003, European journal of pharmacology.
[69] A. Schinkel,et al. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview. , 2003, Advanced drug delivery reviews.
[70] P. Meier,et al. Transport of xenobiotics across the blood-brain barrier. , 2002, News in physiological sciences : an international journal of physiology produced jointly by the International Union of Physiological Sciences and the American Physiological Society.
[71] O. Meijer,et al. The role of the efflux transporter P-glycoprotein in brain penetration of prednisolone. , 2002, The Journal of endocrinology.
[72] A. Enomoto,et al. Human organic anion transporters and human organic cation transporters mediate renal transport of prostaglandins. , 2002, The Journal of pharmacology and experimental therapeutics.
[73] H. Endou,et al. Human organic anion transporters and human organic cation transporters mediate renal antiviral transport. , 2002, Journal of Pharmacology and Experimental Therapeutics.
[74] S. Nigam,et al. The organic anion transporter family: from physiology to ontogeny and the clinic. , 2001, American journal of physiology. Renal physiology.
[75] M. Pfaffl,et al. A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.
[76] Dao-Yi Yu,et al. Oxygen Distribution and Consumption within the Retina in Vascularised and Avascular Retinas and in Animal Models of Retinal Disease , 2001, Progress in Retinal and Eye Research.
[77] D. Hu,et al. Characterization of a novel cationic drug transporter in human retinal pigment epithelial cells. , 2001, The Journal of pharmacology and experimental therapeutics.
[78] G. Szakács,et al. MDR3 P-glycoprotein, a Phosphatidylcholine Translocase, Transports Several Cytotoxic Drugs and Directly Interacts with Drugs as Judged by Interference with Nucleotide Trapping* , 2000, The Journal of Biological Chemistry.
[79] T. Cihlar,et al. Fluorescence-based assay for the interaction of small molecules with the human renal organic anion transporter 1. , 2000, Analytical biochemistry.
[80] T. Cihlar,et al. Cytotoxicity of antiviral nucleotides adefovir and cidofovir is induced by the expression of human renal organic anion transporter 1. , 2000, Journal of the American Society of Nephrology : JASN.
[81] V. Ganapathy,et al. Expression of the extraneuronal monoamine transporter in RPE and neural retina , 2000, Current eye research.
[82] J. Nezu,et al. Na(+)-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance. , 1999, The Journal of pharmacology and experimental therapeutics.
[83] T. Cihlar,et al. The antiviral nucleotide analogs cidofovir and adefovir are novel substrates for human and rat renal organic anion transporter 1. , 1999, Molecular pharmacology.
[84] Kazuhito Yamada,et al. Characterization of cyclosporin A transport in cultured rabbit corneal epithelial cells: P-glycoprotein transport activity and binding to cyclophilin. , 1999, Investigative ophthalmology & visual science.
[85] J. Nezu,et al. Novel membrane transporter OCTN1 mediates multispecific, bidirectional, and pH-dependent transport of organic cations. , 1999, The Journal of pharmacology and experimental therapeutics.
[86] P J Sinko,et al. Interactions of a nonpeptidic drug, valacyclovir, with the human intestinal peptide transporter (hPEPT1) expressed in a mammalian cell line. , 1999, The Journal of pharmacology and experimental therapeutics.
[87] M. Prausnitz,et al. Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye. , 1998, Journal of pharmaceutical sciences.
[88] A. Guo,et al. Direct evidence for peptide transporter (PepT1)-mediated uptake of a nonpeptide prodrug, valacyclovir. , 1998, Biochemical and biophysical research communications.
[89] R. D. Stulting,et al. Acyclovir for the prevention of recurrent herpes simplex virus eye disease. Herpetic Eye Disease Study Group. , 1998, The New England journal of medicine.
[90] B. Hagenbuch. Molecular Properties of Hepatic Uptake Systems for Bile Acids and Organic Anions , 1997, The Journal of Membrane Biology.
[91] M. Dana,et al. Immunity causing blindness: five different paths to herpes stromal keratitis. , 1997, Immunology today.
[92] K. Kontturi,et al. Characterization of paracellular and aqueous penetration routes in cornea, conjunctiva, and sclera. , 1997, Investigative ophthalmology & visual science.
[93] W. Pardridge. Advances in cell biology of blood-brain barrier transport. , 1991, Seminars in cell biology.
[94] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[95] K. Yoshinari,et al. Role of human hepatocyte nuclear factor 4alpha in the expression of drug-metabolizing enzymes and transporters in human hepatocytes assessed by use of small interfering RNA. , 2007, Drug metabolism and pharmacokinetics.
[96] I. Tamai,et al. Identification of influx transporter for the quinolone antibacterial agent levofloxacin. , 2007, Molecular pharmaceutics.
[97] V. H. Lee,et al. Characterization of brimonidine transport in retinal pigment epithelium. , 2006, Investigative ophthalmology & visual science.
[98] A. Wenzel,et al. Localization of organic anion transporting polypeptides in the rat and human ciliary body epithelium. , 2005, Experimental eye research.
[99] M. Tomi,et al. Advances in the cell biology of transport via the inner blood-retinal barrier: establishment of cell lines and transport functions. , 2005, Biological & pharmaceutical bulletin.
[100] Joan W. Miller,et al. Ocular Tissue Permeabilities , 2004, International ophthalmology clinics.
[101] E. Babu,et al. Human organic anion transporters mediate the transport of tetracycline. , 2002, Japanese journal of pharmacology.
[102] P. Borst,et al. Mammalian ABC transporters in health and disease. , 2002, Annual review of biochemistry.
[103] H. Koepsell,et al. Organic cation transporters in intestine, kidney, liver, and brain. , 1998, Annual review of physiology.
[104] G. Bensi,et al. Human interleukin-1 beta gene. , 1987, Gene.